Plunkett Research Online: Johnson & Johnson

JOHNSON & JOHNSON (JNJ:NYS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division .....



Johnson & Johnson
Ticker: JNJ
Exchange: NYS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 732 524-0400
Fax: 732 214-0332
Address: One Johnson and Johnson Plaza
New Brunswick, NJ 08933 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Personal Health Care & Hygiene Products
Sterilization Products
Surgical Products
Pharmaceuticals
Skin Care Products
Baby Care Products
Contact Lenses
Medical Equipment
1. Johnson & Johnson93,775,000,000
2. Pfizer Inc81,288,000,000
3. Roche Holding AG65,768,480,000
4. AbbVie Inc56,197,000,000
5. Novartis AG52,877,000,000
6. Merck & Co Inc48,704,000,000
7. Bristol-Myers Squibb Company46,385,000,000
8. Bayer AG44,952,170,000
9. Abbott Laboratories43,075,000,000
10. Sanofi SA39,949,210,000
Contacts Description
Joaquin DuatoCEO/Director
Joseph WolkCFO/Executive VP
Alex GorskyChairman of the Board/Director
Ashley McEvoyChairman, Divisional/Executive VP
Jennifer TaubertChairman, Divisional/Executive VP
Thibaut MongonChairman, Divisional/Executive VP
Robert DeckerChief Accounting Officer/Controller
James SwansonChief Information Officer/Executive VP
Jennifer DoudnaDirector
Mary BeckerleDirector
A. WashingtonDirector
Mark McClellanDirector
Anne MulcahyDirector
Charles PrinceDirector
D. DavisDirector
Marillyn HewsonDirector
Ronald WilliamsDirector
Hubert JolyDirector
Ian DavisDirector
Darius AdamczykDirector
Nadja WestDirector
Mark WeinbergerDirector
Vanessa BroadhurstExecutive VP, Divisional
Mathai MammenExecutive VP, Divisional
Peter FasoloExecutive VP/Other Executive Officer
William HaitExecutive VP/Other Executive Officer
Kathryn WengelExecutive VP/Other Executive Officer
Michael UllmannGeneral Counsel/Executive VP
Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division .....
See More

Auditor: PricewaterhouseCoopers LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
202120202019201820172016
Financials
    Revenue93,775,000,00082,584,000,00082,059,000,00081,581,000,00076,450,000,00071,890,000,000
    Cost of Revenue29,855,000,00028,427,000,00027,556,000,00027,091,000,00025,354,000,00021,685,000,000
    Gross Margin %68.1665.5866.4266.7966.8469.84
    R&D Expense14,714,000,00012,159,000,00011,355,000,00010,775,000,00010,554,000,0009,095,000,000
    Operating Income24,547,000,00019,914,000,00020,970,000,00021,175,000,00019,122,000,00021,165,000,000
    Operating Margin %26.1824.1125.5525.9625.0129.44
    SGA Expense24,659,000,00022,084,000,00022,178,000,00022,540,000,00021,420,000,00019,945,000,000
    Net Income20,878,000,00014,714,000,00015,119,000,00015,297,000,0001,300,000,00016,540,000,000
    Earnings Per Share7.935.595.725.700.486.04
    Dividends4.193.983.753.543.323.15
    Book Value Per Share - - 22.1124.2727.5826.75
    Operating Cash Flow23,410,000,00023,536,000,00023,416,000,00022,201,000,00021,056,000,00018,767,000,000
    Capital Expenditure3,652,000,0003,347,000,0003,498,000,0003,670,000,0003,279,000,0003,226,000,000
    Free Cash Flow19,758,000,00020,189,000,00019,918,000,00018,531,000,00017,777,000,00015,541,000,000
Profitability
    EBITDA30,349,000,00023,929,000,00024,655,000,00025,933,000,00024,249,000,00024,283,000,000
    Return on Assets %11.708.859.739.860.8712.05
    Return on Equity %30.4123.9725.3625.511.9923.37
    Net Margin %22.2617.8218.4218.751.7023.01
    Assets Turnover0.530.500.530.530.510.52
    Financial Leverage2.462.762.652.562.612.01
Brands, Divisions and Affiliates Top Salaries
Motrin
Band-Aid
Listerine
Tylenol
Neosporin
Risperdal Consta
Remicade
Momenta Pharmaceuticals Inc
NameTitleSalary (US$)Bonus (US$)
Alex GorskyCEO/Chairman of the Board/Director1,650,0000
Paulus StoffelsChief Scientific Officer/Other Corporate Officer1,222,5000
Joaquin DuatoOther Corporate Officer1,030,0000
Jennifer TaubertExecutive VP, Divisional938,0770
Joseph WolkCFO/Executive VP938,0770
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: